Fig. 1From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancerExpression pattern of NNMT in ovarian cancer tissues. a Differential expression of NNMT between FTs and POCs/PTCs. b Differential expression of NNMT between primary ovarian tumors and matched omental metastases. c Differential expression of NNMT between tumors with recurrence and tumors with no-recurrence. d Differential expression of NNMT between LVSI-positive ovarian cancers and LVSI-negative ovarian cancersBack to article page